Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Markers Associated With Response to Intravenous Ketamine

NCT04695405 is registered in ClinicalTrials.gov with Brain and Cognition Discovery Foundation as lead sponsor.

NCT NCT04695405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Markers Associated With Response to Intravenous Ketamine
Lead sponsor
Brain and Cognition Discovery Foundation
Phase
Observational
Overall status
Completed
Start date
January 21, 2021
Completion date
July 2, 2021
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression